Viewing Study NCT03862833


Ignite Creation Date: 2025-12-25 @ 3:05 AM
Ignite Modification Date: 2026-01-01 @ 4:42 AM
Study NCT ID: NCT03862833
Status: COMPLETED
Last Update Posted: 2023-10-06
First Post: 2019-02-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Zoledronic Acid in Combination With Interleukin-2 to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical Allotransplant
Sponsor: Nantes University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module